Open Access

Comparative analysis of full genomic sequences among different genotypes of dengue virus type 3

  • Chwan-Chuen King1,
  • Day-Yu Chao2Email author,
  • Li-Jung Chien3,
  • Gwong-Jen J Chang4,
  • Ting-Hsiang Lin3,
  • Yin-Chang Wu3 and
  • Jyh-Hsiung Huang3
Virology Journal20085:63

https://doi.org/10.1186/1743-422X-5-63

Received: 28 January 2008

Accepted: 21 May 2008

Published: 21 May 2008

Abstract

Background

Although the previous study demonstrated the envelope protein of dengue viruses is under purifying selection pressure, little is known about the genetic differences of full-length viral genomes of DENV-3. In our study, complete genomic sequencing of DENV-3 strains collected from different geographical locations and isolation years were determined and the sequence diversity as well as selection pressure sites in the DENV genome other than within the E gene were also analyzed.

Results

Using maximum likelihood and Bayesian approaches, our phylogenetic analysis revealed that the Taiwan's indigenous DENV-3 isolated from 1994 and 1998 dengue/DHF epidemics and one 1999 sporadic case were of the three different genotypes – I, II, and III, each associated with DENV-3 circulating in Indonesia, Thailand and Sri Lanka, respectively. Sequence diversity and selection pressure of different genomic regions among DENV-3 different genotypes was further examined to understand the global DENV-3 evolution. The highest nucleotide sequence diversity among the fully sequenced DENV-3 strains was found in the nonstructural protein 2A (mean ± SD: 5.84 ± 0.54) and envelope protein gene regions (mean ± SD: 5.04 ± 0.32). Further analysis found that positive selection pressure of DENV-3 may occur in the non-structural protein 1 gene region and the positive selection site was detected at position 178 of the NS1 gene.

Conclusion

Our study confirmed that the envelope protein is under purifying selection pressure although it presented higher sequence diversity. The detection of positive selection pressure in the non-structural protein along genotype II indicated that DENV-3 originated from Southeast Asia needs to monitor the emergence of DENV strains with epidemic potential for better epidemic prevention and vaccine development.

Background

Dengue fever (DF) and its more severe forms, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), have emerged as major public health problems in tropical and subtropical areas [1, 2]. Infection with dengue viruses (DENV), which are maintained in a human-mosquito transmission cycle involving primarily Aedes aegypti and Aedes albopictus, can result in various clinical manifestations ranging from asymptomatic to DF, DHF, DSS and death [3]. The occurrences of dengue epidemics in the past 30 years have been characterized by the rising incidence rates of infection and continuous expansion in geographic distribution of DHF epidemics [4]. Importantly, the epidemics of DHF have become progressively larger in the last 20 years in many dengue endemic countries [5]. The increasingly widespread distribution and the rising incidence of DF and DHF are related to increased distribution of A. aegypti, global urbanization and rapid and frequent international travel.

Epidemiological analysis reveals that some DENV strains are associated with mild epidemics with low occurrences of DHF cases and inefficient virus transmission, whereas others are more likely to cause severe epidemics with high incidence of DHF/DSS and rapid virus transmission [6, 7]. The large DHF epidemics in Indonesia in the 1970s and Sri Lanka after 1989 provided evidence supporting this phenomenon [8, 9]. Dengue virus serotype 3 (DENV-3) re-appeared in Latin Americain 1994 after its absence for seventeen years. The virus was detected initially in Panama and soon dispersed throughout Central and South America during the following years [10, 11]. This introduction coincided with an increased number of DHF cases in this region. Although the genotype originating in Southeast Asia has been postulated as the major cause of the increased virulence, the molecular marker associated with a difference in virulence among genotypes at the full-genomic level is still largely unknown.

Dengue is caused by four antigenically related but genetically distinct viruses (DENV-1, -2, -3 and -4) belonging to the genus Flavivirus, family Flaviviridae [12]. DENV is a single stranded, positive-sense RNA virus, approximately 10,700 nucleotides in length. The genome contains a single open reading frame (ORF) that encodes a polyprotein, which is co- and post-translationally processed to produce three structural proteins, including capsid (C), pre-membrane (prM) and envelope (E), and seven nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) [12, 13]. A considerable number of studies have revealed that each serotype of DENV is composed of phylogenetically distinct clusters that have been classified into "genotypes" or "subtypes," and each genotype is also composed of phylogenetically distinct "groups" or "clades." A previous study has classified DENV-3 strains into four genotypes based on limited numbers of nucleic acid sequences from the prM and E protein genes [6]; DENV-3 strains have also been re-classified into five genotypes [14]. Growing evidence suggests the existence of DENV strains with different epidemic potentials. This evidence is supported by the following observations: (1) the differences in fitness among various genotypes of DENV-2 reflect their different replication capabilities in human monocytes and dendritic cells [15]; (2) around 1991, clade replacement among DENV-3 genotype II containing isolates from Thailand was associated with changing serotype prevalence and incidence of DHF epidemics [16]; and (3) sudden changes in the genotype of DENV at a single locality have been observed that appeared to originate from the genetic bottleneck of a large viral population [14, 17]. This sudden genotype replacement has been associated with more severe DHF epidemics in Indonesia and Sri Lanka [9, 18]. However, most of these studies involved the E gene alone. This raises an important question: Is the introduction of different DENV genotypes in disparate geographical locations a result of sequence differences outside of the E gene altering their epidemic potential, or it is simply a stochastic event in viral evolution?

Dengue epidemics in Taiwan are usually initiated by imported index cases (King et al., 2000). The re-emergence of dengue outbreaks in Taiwan started when DENV-2 was re-introduced into the off-islet of Hsiao-Liu-Chiu in 1981. In 1987–1988, another large-scale DENV-1 outbreak occurred in Kaohsiung and Pingtung in southern Taiwan [19]. Although DENV-3 was detected sporadically from imported index cases, no DENV-3-related epidemic occurred until 11 DHF cases were confirmed in Kaohsiung in 1994 and 23 DHF cases in Tainan in 1998 [20]. Taiwan neighbors many Southeast Asian countries and more than 25,000 travelers visit these adjacent countries annually. The surveillance system implemented by the Center for Disease Control in Taiwan (Taiwan-CDC) routinely detects many imported dengue cases each year. Thus, Taiwan is an ideal place to study the evolution and dispersion of DENV that may have different epidemic potential, particularly in the 1994 and 1998 DHF epidemics in Taiwan that coincided with the DHF epidemics in Southeast Asian countries [21]. Complete genomic sequencing of DENV-3 strains collected from different geographical locations and isolation years offers the opportunity to understand the genetic stasis and possible selection pressure sites in the DENV genome other than within the E gene.

Methods

Sources of DENV-3 viruses

The blood samples of suspected dengue patients, obtained from the sentinel hospitals/clinics located in Tainan, Kaohsiung and Pingtung in southern Taiwan, were sent to the Infectious Disease Epidemiology Laboratory at National Taiwan University (NTU) and Taiwan-CDC for laboratory confirmation. The study protocol was approved by the College of Public Health Research Human Subject Ethics Review Committee at NTU. A suspected and confirmed dengue case was defined as previously described and confirmed by both laboratories [20, 22]. Imported and indigenous dengue cases were defined based on the patients' travel history to dengue-endemic or -epidemic countries within 3–14 days before the onset of the disease.

Due to few DENV-3 epidemics and limited DENV-3 isolates identified before 1998 in Taiwan, we focused our study on comparing the sequences of different DENV-3 isolates in 1998 and considering various epidemiological characteristics, including temporal, geographical and host factors. Six DENV-3 isolates were selected for full-length sequencing: (1) an isolate from the imported DENV-3 infected case in 1998; (2) an isolate from the indigenous DF and DHF cases during the 1998 epidemic in Tainan, Taiwan; (3) the 1998 isolate from a geographical location in Tainan other than the 1998 epidemic area; (4) an isolate from the same geographical location as the 1998 Tainan's epidemic but in 1999; and (5) an isolate from indoor mosquitoes during the 1998 dengue/DHF epidemic in Tainan. The epidemiological characteristics of these six DENV-3 isolates are summarized in Table 1, and their GeneBank accession numbers are DQ675520–DQ675533. In addition to the 1998–99 DENV-3 strains, four local isolates obtained from Taiwan during previous years, kindly provided by Taiwan-CDC, were also used for comparison, including four strains isolated from indigenous DF patients during the 1994–95 epidemic in Kaohsiung [94TWKH33 (Accession No.: DQ675534), 94TWKH65 (Accession No.: DQ675535), 94TWKH25 (Accession No.: DQ675536), 95TW466 (accession No.: DQ675519)]. Isolate 95TW466 with low passage history (two passages in C6/36 cells) was subjected to full-length genomic sequencing together with the above six isolates from 1998–99, constituting seven full-length DENV-3 sequences from Taiwan. The remaining three 1994 DENV-3 isolates were sequenced only from the 5' NCR to the COOH-terminus of the E gene region for phylogenetic analysis.
Table 1

Characteristics of the full-length genome sequences of the DENV-3 isolates investigated in this study

Geographic origin

Disease Statusa

Year

Strain

Genotype

Passage historyb

GenBank accession no

Philippines

?

1956

H87

V

C6/36, SMB

M93130

Guangxi China

?

1980

80-2

V

?

AF317645

Thailand

DF

1994

C0360/94

II

?

AY923865

Thailand

DHF

1994

C0331/94

II

?

AY876494

Indonesia, Jakarta

DF

2004

TB55i

I

?

AY858048

Indonesia, Jakarta

DF

2004

TB16

I

?

AY858047

Indonesia, Jakarta

DF

2004

PI64

I

?

AY858046

Indonesia, Jakarta

DF

2004

PH86

I

?

AY858045

Indonesia, Jakarta

DF

2004

KJ71

I

?

AY858044

Indonesia, Jakarta

DF

2004

KJ46

I

?

AY858043

Indonesia, Jakarta

DF

2004

KJ30i

I

?

AY858042

Indonesia, Jakarta

DF

2004

FW06

I

?

AY858041

Indonesia, Jakarta

DF

2004

FW01

I

?

AY858040

Indonesia, Jakarta

DF

1998

den3_98

I

?

AY858039

Indonesia, Jakarta

DF

1988

den3_88

I

?

AY858038

Indonesia, Jakarta

DF

2004

BA51

I

?

AY858037

Indonesia

Vaccine candidate

 

Sleman/78

I

?

AY648961

Singapore

unknown

1995

Singapore 8120/95

II

?

AY766104

Indonesia, Sumatra

DF

1998

98902890

I

?

AB189128

Indonesia, Sumatra

DHF

1998

98901517

I

?

AB189127

Indonesia, Sumatra

DSS

1998

98901437

I

?

AB189126

Indonesia, Sumatra

DSS

1998

98901403

I

?

AB189125

Brazil

DSS

2002

BR74886/02

III

?

AY679147

Martiniquw

?

1999

D3/H/IMTSSA-MART/1999/1243

III

?

AY099337

Sri Lanka

?

2000

D3/H/IMTSSA-SRI/2000/1266

III

?

AY099336

Taiwan(Kaoshiung)

DF

1995

95TW466

I

AP61 2, C6/36 1

In this study

Taiwan Indonesia-imported

DF

1998

98TW182

II

C6/36 1

In this study

Taiwan (Pingtung)

DF

1998

98TW358

II

C6/36 1

In this study

Taiwan (Tainan)

DF

1998

98TW364

II

C6/36 1

In this study

Taiwan (Tainan)

DHF

1998

98TW368

II

C6/36 1

In this study

Taiwan (Tainan)

mosq

1998

98TWmosq

II

C6/36 1

In this study

Taiwan (Tainan)

DF

1999

99TW628

III

C6/36 1

In this study

a. ? indicates no information available about the disease status of the patient from which the virus was isolated.

b. ? indicates no information available about the passage history of the virus strains. The C6/36 or AP61 number indicates that the virus strain was obtained after the noted number of passages in a C6/36 or AP61 mosquito cell line infected with the original patient's plasma sample. SMB indicates suckling mice brain inoculation.

Viral RNA extraction, RT-PCR and nucleotide sequencing

Acute-phase serum or plasma samples collected from the dengue patients within seven days after the onset of fever were used for both virus isolation and molecular diagnosis [23, 24]. Molecular diagnosis by reverse transcriptase polymerase chain reaction (RT-PCR) amplification and subsequent nucleic acid sequencing was performed as previously described, and a complete list of the PCR and sequencing primers utilized is available upon request [25]. The RNA genomic 5' and 3' terminal 20 nucleotide sequences were not confirmed independently and were assumed to be of the same length and sequence as the prototype strain H87 in this study.

DENV-3 Viral Sequence and Phylogenetic analysis

A total of 25 complete genomic sequences of DENV-3 strains and one DENV-1 strain A88 (GenBank accession number AB074761) were aligned using the multiple sequences alignment ClustalX [26]. These sequences were further combined with all available sequences of the complete E gene or the complete prM and partial E genes (to nucleotide position 1140 of the E gene) of DENV-3 deposited in the GenBank database at the National Center for Biotechnology Information (NCBI). Therefore, the complete E gene (1479 nt) dataset consisting of a total of 168 sequences and the prM and partial E gene (705 nt) dataset of a total of 195 sequences were used for phylogenetic analysis. A complete list of the sequences along with associated epidemiological information is available upon request.

The percentage of sequence similarities and differences were calculated using Bioedit v3.6 program [27]. Pairwise comparisons of both nucleotide and amino acid sequences of DENV-3 isolates were performed using the program MEGA v3.1 (Molecular Evolutionary Genetics Analysis, Pennsylvania State University, PA) to determine the mean and range of the proportional difference (p-distance) [28]. The model of nucleotide substitution that best described DENV-3 sequence evolution was identified using the program Modeltest 3.0 [29]. The resulting most complex GTR+I+Γ substitution model (general time reversible model, GTR, a proportion of sites modeled as invariant, I, variation in rates among sites modeled using the gamma distribution, Ã) was selected to be the best fit to the data using the hierarchical likelihood ratio tests (hLRTs) and Akaine information criterion (AIC). The estimated parameter values from this model were as follows: relative substitution rates among nucleotides were A ↔ C = 1.6120, A ↔ G = 9.5789, A ↔ T = 1.7255, C ↔ G = 0.6272, C ↔ T = 29.7738, G ↔ T = 1.0; proportion of invariable sites (I) was 0.4475; gamma distribution of among-site rate variation (Ã) was 1.2293; and estimated base composition of A = 0.3268, C = 0.2145, G = 0.2539, and T = 0.2048. A maximum likelihood (ML) tree using these parameter settings was estimated using the DNAML in Phylip v3.6 package [30]. Bootstrap analysis with 1,000 re-samplings was used to determine confidence values for groupings within the phylogenetic tree. In addition, a posterior probability distribution tree, generated by implementing the recently developed Bayesian hierarchical phylogenetic model utilizing a Metropolis-coupled Monte Carlo Markov Chains (MC)3 algorithm in the MrBayes program (version 3.1, [31]) was compared with the evolutionary tree of DENV-3 generated by the ML method. Indeed, the Bayesian approaches for constructing phylogenetics have several advantages. First, the primary analysis often provides faster estimates of the tree and measurements than the estimates obtained using ML bootstrapping techniques. Secondly, Bayesian model selection offers advantages over likelihood methods in that the competing evolutionary hypotheses need not to be nested, and it does not rely on standard likelihood assumptions. In other words, the starting trees in Bayesian method are randomly chosen, and multiple runs of the same dataset are generally made with different starting trees to check convergence of the process. The programs' default settings for prior probability were used in our analysis. Bayesian Markov Chain Monte Carlo (BMCMC) processes, considering the heterogeneity in the evolutionary process and thus incorporating a discrete gamma distribution of four classes of substitution rates across mutation sites, were run for 500,000 generations. Output trees were sampled every 100 generations but the first 1,000 trees were discarded before the process reached the convergence state. The resulting trees were rooted using a DENV-1 strain A88 isolate as described.

To analyze the selection pressure in DENV-3, the CODEML program from the PAML package was employed by implementing a maximum-likelihood method. This method presents major advantages over simpler pairwise comparisons in considering the transition/transversion rate bias, non-uniform codon usage, and phylogenetic relationships among the sequences [32]. Positive selection at a small number of codons can be detected by comparing various models of codon evolution which differ in how the rates of synonymous (dS) and nonsynonymous (dN) substitutions (denoted as ω) are treated among codons or within lineages using likelihood ratio tests. To analyze selection pressures at individual codons, we compared the M7 and M8 model. In the M7 model, 10 categories were assigned and estimated from the data, which specified only neutral evolution; however, the M8 model allowed positive selection by adding an 11th codon category at which dN/dS can exceed 1.0. To examine selection pressures along the lineages, the free ratio model, which allows certain lineages to have ω ratios different from the background, was implemented in the M3 model. Additionally, parameters involving the incorporation of classes of codons where ω >1 were used by comparing the value of the likelihood from M0, in which the specified neutral evolution of ω is constrained to be equal to or less than 1 at all codons among all lineages. The comparison was again assessed using the likelihood ratio test. If positive selection was found, the Bayesian method was applied to identify the specific codon that may have been subjected to positive selection pressure.

Results

Comparison of full-length nucleotide and amino acid sequences among DENV-3 strains from Taiwan

We have determined the complete nucleotide sequences (10,707 nucleotides in length with an ORF of 3,390 amino acids) of the seven different DENV-3 strains from Taiwan (Table 1). The percentages of nucleotide and amino acid identities of the entire ORF among these strains, compared with the prototype DENV-3 strain H87 isolated in the Philippines in 1956, are shown in Table 2. The indigenous DENV-3 isolates from the 1998 epidemic area in Tainan City (98TW364 and 98TW368) and from the sporadic case in Pingtung (98TW358) displayed the highest similarity, with 99.9% sequence identity in both nucleotide and amino acid sequences. The 1998 imported 98TW182 strain showed slightly lower nucleotide and amino acid sequence identity (98%) relative to these 1998 indigenous Taiwanese DENV-3 isolates. The DENV-3 isolates of Taiwan from years other than 1998, including the 1995 Kaoshiung 95TW466 and the 1999 Tainan 99TW628 strains, showed higher sequence diversity compared with the 1998 DENV-3 Taiwan isolates (94% nucleotide and amino acid sequence identity), which suggested that they might have originated from different countries. Further phylogenetic analysis revealed that these viruses belong to different genotypes (Genotype I and III; see the section ''Phylogenetic analysis of DENV-3'' for details).
Table 2

Percentage identity within the entire genome of seven different DENV-3 obtained from Taiwan, as compared with the prototype strain H87.

  

pairwise nucleotide identity (%)

 

Strain

1

2

3

4

5

6

7

8

1

H87

-

95.1

95.0

95.0

95.0

95.3

94.9

95.0

2

98TW182

95.0

-

98.0

98.0

98.0

94.2

94.1

98.0

3

98TW358

95.0

98.0

-

99.9

99.9

94.0

94.2

99.9

4

98TW364

95.0

98.0

100.0

-

99.9

94.0

94.2

99.9

5

98TW368

95.0

97.9

99.9

99.9

-

94.0

94.2

99.9

6

95TW466

95.3

94.0

93.8

93.8

93.8

-

93.9

94.0

7

99TW628

94.8

93.9

94.0

94.0

94.0

93.8

-

94.2

8

98TWmosq

94.9

97.9

99.9

99.9

99.9

93.8

94.0

-

  

pairwise amino acid identity (%)

The upper-right matrix corresponds to nucleotide sequences and the lower-left matrix to the amino acid sequences.

Compared to the prototype strain H87, several unique amino acid substitutions that serve as unique signature sites for each genotype were found within the full genomic sequences of the selected DENV-3 isolates from Taiwan or other countries and are listed by the order of the gene in Table 3. Among those, several substitutions changed the polarity, charges, or hydrophobicity of these amino acids, which were present only in genotype III of DENV-3, including the change from threonine (T) to alanine (A) at position 112 of the C region, leucine (L) to histidine (H) at position 55 of the prM region, L to T at position 301 of the E region, isoleucine (I) to T at position 115 of the NS3 region, and lysine (K) to T and aspartic acid (D) to asparagine (N) at positions 585 and 835 of the NS5 region. Similar signature sites experiencing amino acid property alterations in genotype II included a change from T to A at position 57 of the prM region, L to serine (S) at position 178 of the NS1 region, and A to T at position 133 of the NS2A region. Thus, our data suggested that different genotypes of DENV-3 experience different amino acid changes at both structural and non-structural genes, and the sites of these substitutions could serve as signature sites for genotype identification.
Table 3

Description of amino acid differences among the selected DENV-3 from Taiwan and other countries as compared to reference strain H87

Geno

V

V

I

I

I

I

II

II

II

II

II

III

III

III

III

Strain*

H87

80-2

Ind88

Ind04

TW95

Ind98

Tha94

Sing95

Tw182

Tw358

Tw368

TW99

Martini

SriLan

Brazil

Year

56'

80'

88'

04'

94'

98'

94'

95'

98'

98'

98'

99'

99'

00'

02'

Capsid

35**

R

        

K

K

K

K

K

K

65

V

 

I

I

 

I

         

82

K

 

R

R

R

R

         

97

K

 

R

R

R

R

       

Q

 

108

M

      

I

   

I

I

I

I

112

T

          

A

A

A

A

prM

55

H

 

L

L

L

L

L

L

L

L

L

    

57

T

     

A

A

A

A

A

    

128

L

 

F

F

F

F

         

Envelope

68

I

 

V

V

V

V

V

        

81

I

          

V

V

V

V

124

S

  

L

 

L

P

P

P

P

P

P

P

P

P

132

H

        

Y

Y

Y

Y

Y

Y

154

E

     

D

D

D

D

D

    

160

A

     

V

V

V

V

V

    

169

A

  

V

V

V

 

V

V

V

V

H

T

T

T

231

R

  

K

K

K

         

270

T

     

N

N

N

N

N

N

N

N

N

301

L

  

S

 

S

     

T

T

T

T

303

T

 

A

A

A

A

         

383

K

          

N

N

N

 

452

I

          

V

V

V

V

479

A

  

V

V

V

V

  

V

V

    

NS1

178

L

     

S

S

S

S

S

    

188

V

     

I

I

I

I

I

    

217

L

     

F

F

F

F

F

    

339

N

          

S

S

S

S

NS2A

37

L

          

F

F

F

F

55

H

 

R

R

 

R

         

133

A

     

T

T

T

T

T

    

153

T

 

M

M

M

          

175

I

     

V

V

V

V

V

V

V

V

V

NS3

115

I

          

T

T

T

T

255

R

 

K

K

K

K

         

324

D

     

E

E

E

E

E

    

350

E

 

D

D

 

D

         

356

V

 

A

A

 

A

     

A

A

A

A

452

V

     

A

A

A

A

A

A

A

A

A

589

K

     

R

R

R

R

R

R

   

NS4A

89

I

 

V

V

V

V

         

99

D

          

E

E

E

E

148

V

          

I

I

I

I

115

V

          

I

I

I

I

190

L

 

F

F

F

F

         

NS4B

116

V

          

I

I

I

I

191

L

 

F

F

F

F

         

NS5

281

K

  

R

R

R

         

288

S

          

N

N

N

N

336

M

 

T

T

T

T

         

422

R

  

K

       

K

K

K

K

585

K

          

T

T

T

T

619

I

     

V

V

V

V

V

V

 

V

 

749

R

 

K

K

K

K

K

K

K

K

K

    

835

D

          

N

N

N

N

876

N

     

D

D

D

D

D

    

*The GeneBank accession numbers for the strains of DENV-3 compared are H87: M93130; 80-2: AF317645; Ind88: AY858038; Ind04: AY858040; TW95: DQ675519; Ind98: AY858039; Tha94: AY923865. Sing95: AY766104; TW182: DQ675520; TW358: DQ675522; TW368: DQ675525; TW99: DQ675533; Martini: AY099337; SriLan: AY099336; Brazil: AY679147.

**A blank cell indicates an amino acid identical to that of strain H87.

Phylogenetic analysis of DENV-3

The phylogenetic trees of DENV-3 were constructed from the two different nucleic acid dataset alignments: (1) partial sequences of the prM and E gene region (prM/E) from 10 isolates obtained from Taiwan and 185 sequences available from GenBank; (2) complete E gene sequences including 168 isolates from both Taiwan and GenBank. The trees derived from the maximum likelihood method and the Bayesian method based on both datasets were very similar to each other. Thus, only the posterior probability tree derived from the Bayesian method based on the complete E gene sequences is shown (Fig 1). The DENV-3 strains isolated in Taiwan during the 1994–1995's outbreak were grouped into genotype I, together with the earlier DENV-3 strains from Southeast Asia, including those from Indonesia, Malaysia, the Philippines and the South Pacific islands. However, all the DENV-3 strains isolated during the 1998 dengue/DHF epidemic in Taiwan were classified as genotype II, which consists mainly of viruses from Thailand. Interestingly, the only DENV-3 strain (98TW182) examined that was imported to Taiwan from Indonesia in 1998 did not cluster with the other Indonesia DENV-3 isolates. It is related closely to the isolate from Myanmar from 1998, which grouped with the Thailand isolates into genotype II. Genotype III of DENV-3 consists of the strains from Sri Lanka, India, Africa and Samoa that were recently introduced into Central and South America and caused major DHF epidemics in many countries. The 99TW628 strain, isolated in 1999 from Tainan in Taiwan, belongs to this genotype. Genotype IV, representing the earlier American genotype, consists of the isolates from Puerto Rico in 1963/77 and Tahiti in 1965, and viruses belonging to this genotype have not been isolated since the 1970s. Genotype V consists of the 80-2 strain isolated from China in 1980, the H87 strain isolated from the Philippines in 1956, and the Japanese isolate from an imported case in 1977.
Figure 1

The Bayesian hierarchical consensus tree showing the phylogenetic relationships between DENV-3 genotypes is based on the complete E gene sequences (1479 bp) from the 168 DENV-3 strains sampled globally. The names of the DENV-3 isolates refer to the year of isolation and the country of origin. In cases where there is more than one isolate from a given country and year, a unique isolate number (or code) is also given. The abbreviations of the names of the countries are: Bangladesh (BD), Bolivia (BL), Brazil (Br), Cambodia (Cam), Cuba (Cu), Ecuador (ECU), Indonesia (Indo), Japan (Jap), Martinique (Mart), Mexico (Mexi), Mozambique (Moza), Malaysia (Mal), Myanmar (Mya), Nicaragua (Nic), Peru (PR), Puerto Rico (PueR), Philippines (PH), Singapore (Sin), Sri Lanka (SriL), Tahiti (Tah), Thailand (TH), Taiwan (TW), Venezuela (Ven). Bootstrap values greater than 0.9 based on Bayesian posterior probabilities are shown for key nodes. The major genotypes of DENV-3 are also labeled. The tree was rooted using DENV-1 strain A88 (GenBank accession number: AB074761) as the outgroup. Taiwan DENV-3 isolates are marked with a star.

Sequence divergence in nucleotide and amino acid sequence among various regions of full-length sequences of different genotypes of DENV-3

With the lack of full-length sequences of viruses belonging to old American genotype IV, only four DENV-3 genotypes, including representatives of genotype I (98TW366), genotype II (98TW349), genotype III (98TW628) and genotype V (H87) were compared. The sequence divergences in nucleotide and amino acid were calculated as the p-distance by adjusting the lengths of different genes [25, 33]. The highest nucleotide diversity was found in the NS2A gene (mean ± SD: 5.84 ± 0.54), followed by the E gene (mean ± SD: 5.04 ± 0.32). Similar results were observed for amino acid diversity, which was also the highest in the capsid gene (mean ± SD: 3.13 ± 1.15), followed by the NS2A gene (mean ± SD: 2.57 ± 0.62) (Table 4).
Table 4

Comparison of sequence diversity (p-distance, %) of full-length genomic sequences among different genotypes of dengue virus type 3

 

Capsid

prM

E

NS1

NS2a

NS2b

NS3

NS4a

NS4b

NS5

nucleotide

3.24 ± 0.54

4.37 ± 0.52

5.04 ± 0.32

4.37 ± 0.39

5.84 ± 0.54

4.02 ± 0.59

4.55 ± 0.30

4.21 ± 0.54

3.85 ± 0.41

4.23 ± 0.23

Amino acid

3.13 ± 1.15

1.41 ± 0.53

1.60 ± 0.34

1.54 ± 0.36

2.57 ± 0.62

0.54 ± 0.18

0.99 ± 0.24

1.33 ± 0.53

0.85 ± 0.31

1.17 ± 0.20

Analysis of selection pressure among different viral regions of DENV-3 full-length sequences

To determine whether higher sequence diversity in certain genes could be the result of natural selection pressures, we implemented the M7 and M8 selection models to determine whether positive selection pressure among all codons from the full-length DENV-3 sequences could be detected by using the CODEML program from PAML [32]. The results suggested that both structural and non-structural genes of DENV-3 were under neutral selection. Although the E gene showed positive selection (ω = 2.15) with statistical significance (p = 0.01) when using the larger dataset with 73 sequences, no specific site with positive selection could be detected. To further examine the selection pressure along the lineage, genotype I, II, III and V, based on the phylogenetic tree of the full-length sequences (Fig 2), were examined separately using the M3 model. The results are summarized in Table 5. Although there were positive selection pressures detected in the C and NS4B genes of genotype I, and in the E, NS1 and NS3 genes of genotype II, only the NS1 gene of genotype II showed statistically significant positive selection pressure. Furthermore, positive selection was detected at position 178 of the NS1 gene (substitution of S for L).
Table 5

Positive selection and relevant parameter values among different genomic regions of full-length DENV-3 sequences

Gene

dN/dS

 

Genotype I

Genotype II

Genotype III

Genotype V

Capsid

5.68

0.00001

0.05

0.00001

prM

0.00001

0.14

0.00001

0.00001

E

0.02

999

0.03

0.097

NS1

0.00001

18.2*

0.02

0.66

NS2A

0.00001

0.00001

0.02

0.08

NS2B

0.00001

0.00001

0.00001

0.00001

NS3

0.008

999

0.007

0.04

NS4A

0.04

0.00001

0.08

0.00001

NS4B

19.37

0.00001

0.00001

0.1

NS5

0.00001

0.008

0.018

0.00001

*p < 0.05 with statistical significance

Figure 2

The Maximum likelihood phylogenetic tree shown here is based on the complete genomic sequences of 25 DENV-3 strains available from GenBank. The tree was rooted using DENV-1 strain A88 (GenBank accession number: AB074761) as the outgroup. The major amino acid changes along lineages within genotype I and II are also labeled. Taiwan DENV-3 isolates are marked with a star.

Changes at the 5' and 3' non-coding regions (NCR) and secondary structure analysis

Changes occurring in the 5' NCR and 3' NCR were examined among the DENV-3 viruses isolated in Taiwan and other countries. In the 5' NCR, positions 62, 90, 109 and 112 had nucleotide changes that were distinguishable for the specific genotype. Among them, a G to A change at position 62 was frequently seen in genotype I, a C to T change at position 90 and a G to A change at position 109 were observed only in genotype II, and an A to G change at position 112 was present in genotype III. Interestingly, there was consistently an additional 11-nucleotide sequence, AGTGAAAAAGA, inserted in the 3' NCR close to the end of the open-reading frame (ORF) of the DENV-3 strains isolated in recent years, compared to the prototype strain H87. In the 3' NCR, nucleotide changes at position 111, 129, 220 and 438 (nucleotide numbering beginning at 5'-terminus of 3' NCR after the stop codon) were observed from the strains circulating recently, which differed from the strain H87. However, none of these changes had any effect on the predicted secondary structure of the 3' NCR RNA (data not shown). The putative genome cyclization sequence UCAAUAUG, located between nucleotides 38 and 46 of the C gene, was conserved in all DENV-3 viruses.

Discussion and conclusion

Viral sequence comparisons among isolates from dengue epidemics of different disease severities may provide valuable information regarding the molecular basis of the epidemic potential of the virus. DENV-3 re-appeared in 1998 in Taiwan and caused the DF/DHF epidemic in Tainan City after its first introduction in 1994 [20]. This stimulates a great interest in understanding the molecular relationship of DENV-3 isolates in Taiwan during inter-epidemic periods and in comparing them with the strains circulating globally to understand evolutionary trends and geographical expansions. Here, we confirmed that the dengue epidemics in Taiwan were strongly associated with the globally circulating DENV-3 due to constant introduction of viruses from Southeast Asia by Taiwanese travelers. Our data demonstrates the sequence diversity among the full-genomic sequences of DENV-3 and the positive selection pressures exerted in different lineages (i.e. genotypes) at sites in DENV-3 non-structural genes.

Since most Taiwan dengue epidemics were initiated by the introduction of virus from imported cases [21], phylogenetic analysis provides essential information to understand the history and origin of all Taiwan DENV-3 isolates originating in other countries (Fig. 1). The high nucleotide sequence identity (> 99.8%) among the strains isolated in 1998 indicates that they were from a single origin and further spread to different townships, such as Pingtung (ID#98TW358). The only 1998 imported DENV-3 isolated from a traveler who had recently visited Indonesia was more closely associated with the genotype II isolates from Myanmar and older isolates from Thailand. This virus differed from the virus isolated during the 1998 Tainan outbreak, which might suggest that multiple genotypes of DENV-3 circulated in Indonesia. This observation is consistent with a previous study indicating that at least two subtypes of DENV-3 were present in Indonesia [18]. The phylogenetic analysis also suggested that a single 1999 isolate (ID#99TW628) from the same location as the 1998 epidemic was grouped together with the genotype III Sri Lanka isolates. Additional DENV-3 isolates from the first DENV-3-caused DHF outbreak in Taiwan (1994–1995) were grouped into genotype I. All these results implicated that repeated introductions of different genotypes of DENV-3 into Taiwan since 1994 were important causes of dengue epidemics, and that DENV-3 was not endemic in Taiwan. This situation may be similar in the subtropical region of China. Our country initiated airport fever screening during the severe acute respiratory syndrome (SARS) outbreak in 2003–04, and it successfully identified 40 confirmed, imported dengue cases [22]. Airport fever screening can thus quickly identify imported dengue cases, and may prevent a significant number of dengue outbreaks that would have been initiated by imported index cases. However, its cost-effectiveness in preventing any dengue epidemics in Taiwan will need to be evaluated in the future.

With different DENV-3 genotypes imported into Taiwan from Southeast Asia and other parts of the world, this virus collection provides an excellent opportunity to examine the sequence diversity of different genes of the full-length DENV-3 viral RNA genome for genotypes other than genotype IV. The highest p-distance of nucleotide diversity of the full-length genomes occurred for the NS2A gene (5.84% ± 0.54%), followed by the E gene (5.04% ± 0.32%). In contrast, the highest p-distance of amino acid diversity of the full-length genomes occurred for the capsid gene (3.13% ± 0.96%), followed by the NS2A gene (2.57% ± 0.62%). This observation is consistent with the previous analysis in DENV-1, DENV-3 and DENV-4 [16, 34], although the precise cause of the increased rate of amino acid change in the NS2A gene is unknown. A similar observation could also be made while analyzing the full genomic sequences of West Nile virus (WNV) isolated from different animal species [35]. The flavivirus NS2A, a protein important for viral replication and particle formation [12], is cleaved by viral serine protease. A mutation at the basic P1 cleavage site residue in NS2A blocks this processing event and is lethal for virus production while still allowing RNA replication [36, 37]. Furthermore, this basic residue in NS2A and an acidic residue in NS3 are important determinants for virus assembly and/or release [38]. Although the relative high sequence diversity of the NS2A gene of DENV-3 may be due to the lesser structural constraint required for NS2A, it is possible that positive selection pressures may be exerted on this gene. Especially in light of recent studies, NS2A together with NS4B and NS4A were identified as dengue virus-encoded proteins that could antagonize the interferon (IFN) response during viral infection [39, 40]. Our analysis didn't detect any selection pressure exerted on the NS2A gene probably due to the small sample size; future studies will be needed to focus the selection pressure analysis on non-structural proteins and DENV evolution.

Several evolutionally conserved amino acid changes are preserved, which are unique in different DENV-3 genotypes (Table 3). These substitutions resulted in changes of its polarity, hydrophobicity or charge. Especially notable was the change from L to S at position 178 of the NS1 region, which is an amino acid substitution unique to genotype II. This might be the result of positive selection within the lineage of genotype II but not other genotypes. All DENV-3 isolates from Thailand belong to genotype II, and interestingly, based on a previous publication [16], strains of DENV-3 isolated prior to 1992 in Thailand may have been replaced by two new locally evolving strains. This could be a sign of a new genotype evolving in Thailand; however, most of the mutations or substitutions occurring were deleterious and a purifying selection of DENV-3 was suggested [16]. It is very likely that the previous analysis focused on only the E protein gene. Determining the possibility of a positive natural selection site in the non-structural genes of the new Thailand lineage will require further study. A number of T- and B-cell epitopes are present on the non-structural proteins, especially the NS1 gene [4143]. Even though the biological significance of the L to S change at position 178 of the NS1 region is unclear, growing evidence supported by in vitro and in vivo studies suggest that there are certain evolutionary forces acting on the NS1 gene shaping the gene flow of the dengue viral population, which might differ during viral replication in mammalian and mosquito cells [44, 45]. This is the first time that a positive selection pressure site was detected in a non-structural protein in DENV-3 and its importance together with its functional relevance to epidemic severity will need to be examined with a larger sample size.

The global distribution of different genotypes of DENV-3 indicates that they originated in Southeast Asia; these genotypes demonstrated higher epidemic potential with regards to severe DHF epidemics in Sri Lanka, Central and South America [46, 47]. Genotype III, once its transmission cycle was established locally, soon resulted in DHF epidemics regardless of an increase in virus transmission or a change in circulating serotypes [7, 14], supporting the hypothesis that virus strain is an important risk factor for DHF [48, 49]. Two sub-lineages (isolated before and after 1989) existed within the DENV-3 genotype III strains from Sri Lanka, and the viruses isolated after 1989 were associated with the DHF epidemic [7]. We found that the strain isolated in 1999 from a indigenous dengue patient (99TW628) that did not lead to a large-scale epidemic of DF or DHF was more closely related to the lineage of the DENV-3 genotype III Sri Lankan strain isolated before 1989. Similarly, in Indonesia two sub-lineages of DENV-3 were present (isolated before and after 1998), and a greater DHF epidemic, especially in adult cases, was caused by the DENV-3 strains isolated after 1998 [50]. The DENV-3 strain isolated in Taiwan during the DHF outbreak in 1994 was actually more closely related to the old Indonesian strain of genotype I from 1976–78. While it is currently unknown how the different sub-lineages within each genotype are associated with different DHF epidemic potential, a recent publication suggested that changing serotype prevalence could lead to differential susceptibility to cross-reactive immune responses [16]. Furthermore, Wearing et al suggested that both vector and short-termed host cross-immunity are two factors responsible for dengue epidemics [51]. It would be necessary to strengthen comprehensive dengue virological surveillance, especially in those endemic and hyper-endemic areas/countries, to monitor the emergence of DENV strains with epidemic potential for better epidemic prevention and vaccine development.

Declarations

Acknowledgements

We sincerely thank Shih-Ting Ho at the Sin-Lau Christian Hospital, Chien-Ming Li at the Chi-Mei Foundation Medical Center and Shih-Chung Lin at the Kuo General Hospital for cooperation in kindly providing the clinical samples. The study was supported by the grants from the National Health Research Institute (NHRI), Taipei, Taiwan (grant number: NHRI#DD01-861X-CR-501P and NHRI#CN-CL8903P) and the National Science Council (NSC#90-2320-B-002-200, NSC#91-2320-B-002-081) in Taiwan.

Authors’ Affiliations

(1)
Institute of Epidemiology, College of Public Health, National Taiwan University
(2)
Institute of Veterinary Public Health, College of Veterinary, National Chung-Shin University
(3)
Center for Disease Control, Department of Health
(4)
Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC)

References

  1. Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11: 480-496.PubMed CentralPubMedGoogle Scholar
  2. Pinheiro FP, Corber SJ: Global situation of dengue and dengue haemorrhagic fever and its emergence in the Americas. Wld Hlth Statist Quart 1997, 50: 161-169.Google Scholar
  3. McBride WJH, Bielefeldr-Ohmann H: Dengue viral infections; pathogenesis and epidemiology. Microbes Infect 2000, 2: 1041-1050. 10.1016/S1286-4579(00)01258-2View ArticlePubMedGoogle Scholar
  4. Gubler DJ, Clark GG: Dengue/dengue hemorrhagic fever: The emergence of a global health problem. Emerg Infect Dis 1995, 1: 55-57.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Lucas GN, Amerasinghe A, Sriranganathan S: Dengue haemorrhagic fever in Sri Lanka. Indian J Pediatr 2000, 67: 503-504. 10.1007/BF02760477View ArticlePubMedGoogle Scholar
  6. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW: Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 1994, 75: 65-75.View ArticlePubMedGoogle Scholar
  7. Messer WB, Gubler D, Harris E, Sivananthan K, de Silva AM: Emergence and global spread of a dengue serotype 3, subtype III virus. Emerging Infectious Diseases 2003, 9: 800-809.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Gubler DJ, Suharyono W, Lubis I, Eram S, Saroso JS: Epidemic dengue hemorrhagic fever in rural Indonesia. I. Virological and epidemiological studies. Am J Trop Med Hyg 1979, 28: 701-710.PubMedGoogle Scholar
  9. Messer WB, Vitarana T, Sivananthan K, Elvtigala J, Preethimala LD, Ramesh R, Withana N, Gubler DJ, Silva AM: Epidemiology of dengue in Sri Lank before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 2002, 66: 765-773.PubMedGoogle Scholar
  10. Gubler DJ, Meltzer M: Impact of dengue/dengue hemorrhagic fever on the developing world. Advances in virus research 1999, 53: 35-70.View ArticlePubMedGoogle Scholar
  11. Anonymous: Dengue-3 in Central America. Dengue Surveillance Summary, CDC 1995, 70: 1-4.Google Scholar
  12. Chambers TJ, Hahn CS, Galler R, Rice CM: Flavivirus genome: organization, expression and replication. Annu Rev Microbiol 1990, 44: 649-688. 10.1146/annurev.mi.44.100190.003245View ArticlePubMedGoogle Scholar
  13. Gubler DJ, Kuno G: Dengue and dengue hemorrhagic fever. Cab international, New York 1997, 1-23.Google Scholar
  14. Wittke V, Robb TE, Thu HM, Nisalak A, Nimmannitya S, Kalayanrooj S, Vaughn DW, Endy TP, Holmes EC, Aaskov J: Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology 2002, 301: 148-156. 10.1006/viro.2002.1549View ArticlePubMedGoogle Scholar
  15. Cologna R, Rico-Hesse R: American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 2003, 77: 3929-3938. 10.1128/JVI.77.7.3929-3938.2003PubMed CentralView ArticlePubMedGoogle Scholar
  16. Zhang C, Mammen MPJ, Chinnawirotpisan P, Klungthong C, Rodpradit P, Monkongdee P, Nimmannitya S, Kalayanarooj S, Holmes EC: Clade replacement in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J Virol 2005, 79: 15123-15130. 10.1128/JVI.79.24.15123-15130.2005PubMed CentralView ArticlePubMedGoogle Scholar
  17. Sittisombut N, Sistayanarain A, Cardosa MJ, Salminen M, Damrongdachakul S, Kalayanarooj S, Rojanasuphot S, Supawadee J, Maneekarn N: Possible occurrence of a genetic bottleneck in dengue serotype 2 viruses between the 1980 and 1987 epidemic seasons in Bangkok, Thailand. Am J Trop Med Hyg 1997, 57: 100-108.PubMedGoogle Scholar
  18. Raekiansyah M, Pramesyanti A, Bela B, Kosasih H, Ma'roef CN, Tobing SY, Rudiman PI, Alisjahbana B, Endi TP, Green S, et al.: Genetic variations and relationship among dengue virus type 3 strains isolated from patients with mild or severe form of dengue disease in Indonesia and Thailand. Southeast Asian J Trop Med Public Health 2005, 36: 1187-1197.PubMedGoogle Scholar
  19. Hwang KP: Dengue fever and dengue hemorrhagic fever. J Formosan Med 1997, 1: 48-55.Google Scholar
  20. Chao DY, Lin TH, Hwang KP, Huang JH, Liu CC, King CC: 1998 dengue hemorrhagic fever epidemic in Taiwan. Emerg Infect Dis 2004, 10: 552-554.PubMed CentralView ArticlePubMedGoogle Scholar
  21. King CC, Wu YC, Chao D-Y, Lin TH, Chow L, Wang H-T, Ku C-C, Kao C-L, Chien LJ, Chang H-J, et al.: Major epidemics of dengue in Taiwan in 1981–2000: Related to intensive virus activities in Asia. Dengue Bulletin 2000, 24: 1-10.Google Scholar
  22. Shu P, Chien L, Chang S, Su C, Kuo Y, Liao T, Ho M, Lin T, Huang J: Fever screening at airports and imported dengue. Emerg Infect Dis 2005, 11: 460-462.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Gubler DJ, Kuno G, Sather GE, Velez M, Oliver A: Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 1984, 33: 158-165.PubMedGoogle Scholar
  24. Kao C, Wu M, Chiu Y, Lin J, Wu Y, Yueh Y, Chen L, Shaio M, King C: Flow cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture. J Clin Microbiol 2001, 39: 3672-3677. 10.1128/JCM.39.10.3672-3677.2001PubMed CentralView ArticlePubMedGoogle Scholar
  25. Chao DY, King CC, Wang WK, Chen WJ, Wu HL, Chang GJ: Strategically Examining the Full-Genome of Dengue Virus Type 3 in Clinical Isolates Reveals Its Mutation Spectra. Virology Journal 2005, 24: 72. 10.1186/1743-422X-2-72View ArticleGoogle Scholar
  26. Higgins DG, Sharp PM: CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 1988, 73: 237-244. 10.1016/0378-1119(88)90330-7View ArticlePubMedGoogle Scholar
  27. Hall T: BioEdit: Biological sequence aligment editor for WinXP. Ibis Thearpeutics, Carlsbad, CA92008 2005.Google Scholar
  28. Kumar S, Tamura K, Nei N: MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004, 5: 150-163. 10.1093/bib/5.2.150View ArticlePubMedGoogle Scholar
  29. Posada D, Crandall KA: Modeltest: testing the model of DNA substitution. Bioinformatics 1998, 14: 817-818. 10.1093/bioinformatics/14.9.817View ArticlePubMedGoogle Scholar
  30. Felsenstein J: PHYLIP: Phylogeny Inference Package (Univ. of Wahsington, Seattle), Version 3.5c. 1993.Google Scholar
  31. Huelsenbeck JP, Ronquist F: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001, 17: 754-755. 10.1093/bioinformatics/17.8.754View ArticlePubMedGoogle Scholar
  32. Yang Z: PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 1997, 13: 555-556.PubMedGoogle Scholar
  33. Wang W-K, Lin S-R, Lee C-M, King C-C, Chang S-C: Dengue type 3 virus in plasma is a population of closely related genomes:quasispecies. J Virol 2002, 76: 4662-4665. 10.1128/JVI.76.9.4662-4665.2002PubMed CentralView ArticlePubMedGoogle Scholar
  34. Klungthong C, Zhang C, Mammen MPJ, Ubol S, Holmes EC: The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virol 2004, 329: 168-179. 10.1016/j.virol.2004.08.003View ArticleGoogle Scholar
  35. Lanciotti R, Ebel G, Deubel V, Kerst A, Murri S, Meyer R, Bowen M, McKinney N, Morrill W, Crabtree M, et al.: Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virol 2002, 298: 96-105. 10.1006/viro.2002.1449View ArticleGoogle Scholar
  36. Lindenbach BD, Rice CM: Flaviviridae : The viruses and their replication, p.991–1110. In Fields' Virology. 4th edition. Edited by: Knipe DM, Howley PM. Lippincott Williams & Wilkins, Philadelphia, PA; 2001.Google Scholar
  37. Hori H, Lai CJ: Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1. J Virol 1990, 64: 4573-4577.PubMed CentralPubMedGoogle Scholar
  38. Preugschat F, Yao CW, Strauss JH: In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J Virol 1990, 64: 4364-4374.PubMed CentralPubMedGoogle Scholar
  39. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A: Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci 2003, 100: 14333-14338. 10.1073/pnas.2335168100PubMed CentralView ArticlePubMedGoogle Scholar
  40. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005, 79: 8004-8013. 10.1128/JVI.79.13.8004-8013.2005PubMed CentralView ArticlePubMedGoogle Scholar
  41. Falconar AKI, Young PR, Miles MA: Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein. Arch Virol 1994, 137: 315-326. 10.1007/BF01309478View ArticlePubMedGoogle Scholar
  42. Garcia G, Vaughn DW, del Angel RM: Recognition of snthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue-4 virus by sera from dengue virus-infected children. Am J Trop Med Hyg 1997, 56: 466-470.PubMedGoogle Scholar
  43. Callahan JD, Wu S-JL, Dion-Schultz A, Mangold BE, Peruski LF, Watts DM, Porter KR, Murphy GR, Suharyono W, King C-C, et al.: Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus. J Clin Microbiol 2001, 39: 4119-4124. 10.1128/JCM.39.11.4119-4124.2001PubMed CentralView ArticlePubMedGoogle Scholar
  44. Blaney JJ, Manipon GG, Murphy BR, Whitehead SS: Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural proteins of dengue virus type 4 restrict replication in the brains of mice. Arch Virol 2003, 148: 999-1006. 10.1007/s00705-003-0007-yView ArticlePubMedGoogle Scholar
  45. Chen WJ, Wu HR, Chiou SS: E/NS1 modifications of dengue 2 virus after serial passages in mammalian and/or mosquito cells. Intervirology 2003, 46: 289-295. 10.1159/000073208View ArticlePubMedGoogle Scholar
  46. Usuku S, Castillo L, Sugimoto C, Noguchi Y, Yogo Y, Kobayashi N: Phylogenetic analysis of dengue-3 viruses prevalent in Guatemala during 1996–1998. Arch Virol 2001, 146: 1381-1390. 10.1007/s007050170098View ArticlePubMedGoogle Scholar
  47. Palacio M, Amadoor JJ, Acevedo F, de los Reyes J, Ramirez A, Gonzalez A, Guelva G: Internaltional notes dengue type 3 infection – Nicaragua and Panama, October-November 1994. Morb Mortal Wkly Rep (MMWR) 1995, 44: 21-24.Google Scholar
  48. Gubler DJ: Cities spawn epidemic dengue viruses. Nat Med 2004, 10: 129-130. 10.1038/nm0204-129View ArticlePubMedGoogle Scholar
  49. Rosen L: Disease exacerbation caused by sequential dengue infections: myth or reality? Rev Infect Dis 1989, 11: S840-842.View ArticlePubMedGoogle Scholar
  50. Mcardle JL, Listyaningsih E, Suharyono W, Porter KR: Evolution of the dengue-3 virus in Indonesia and throughout SE Asia may contribute to recent changes in outbreak dynamics. International Conference on Emerging Infectious Diseases, July 16–19, 2000 Atlanta, Georgia, USA 2000. conference abstract, board 68Google Scholar
  51. Wearing HJ, Rohani P: Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci 2006, 103: 11802-11807. 10.1073/pnas.0602960103PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© King et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.